The Evolution of Workflow Management in Pharma

The pharmaceutical sector’s shift to agentic workflow management reflects a broader transformation across industries. Traditional process automation tools—digital process automation (DPA), robotic process automation (RPA), and document automation—have streamlined operations for decades. Yet, as generative AI (genAI) introduces new possibilities, Pharma companies are rethinking how best to balance operational reliability with innovation.

Agentic AI is particularly suited to the high-stakes, complex environment of Pharma, where workflows encompass regulatory compliance, clinical trial management, commercialisation, and global supply chain operations. Unlike rule-based automation, which requires explicit configuration for every exception, agentic AI systems possess the autonomy to adapt to the unpredictability of real-world pharmaceutical processes.

Defining Agentic Workflow Management

Agentic workflows leverage AI agents that operate independently, learn over time, and adapt to evolving conditions. This approach addresses two main limitations of traditional tools:

1. Brittle Customisation: Traditional systems are highly configured and inflexible. Agentic systems can handle unstructured tasks, adjusting their workflow paths autonomously.
2. Task-Centric vs. Goal-Oriented: Agentic AI prioritises goal achievement over specific task execution, allowing for a more holistic approach where AI determines the optimal path for multi-layered, dynamic workflows.